get a key
steadybase-$ company GCTK
account_id none on file
legal_name Glucotrack, Inc.
ticker GCTK
cik 1506983
domain glucotrack.com
entry_point_account_id none on file
name GlucoTrack Inc.
exchange Nasdaq
sector Health Care
hq Rutherford, NJ, United States
calls 0 filings 4 executives 9 family 0
why_nownone on file
callsnone on file
filings
materials, travel expenses, clinical trials and other expenses. We expect research and development expenses to increase in 2026 and beyond,

filing / Aug 14, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our products.

filing / Aug 14, 2026 / receipt

our international expansion efforts, our ability to attract and retain employees, and our business, prospects, operating results, and

filing / Aug 14, 2026 / receipt

Erik Emerson Chief Executive Officer

filing / Aug 10, 2026 / receipt

executives
Angela Strand Vice Chairman - receipt
David Podwalski Chief Commercial Officer - receipt
Erez Ben-Zvi Vice President - receipt
Erik Emerson Chief Executive Officer - receipt
Erin Carter director - receipt
Israel Ehrlich director - receipt
John Graham Chief Executive Officer - receipt
Leslie Seff director - receipt
Peter C. Wulff Chief Financial Officer linkedin receipt
familynone on file
upcoming
2026-11-12 earnings call scheduled
changes
2025-01-29 Chief Financial Officer, appointed sec_8k
2023-10-12 Chief Financial Officer, departed sec_8k
2023-08-31 director, appointed sec_8k
2021-02-08 Vice President, appointed sec_8k
2019-08-08 Chief Financial Officer, departed sec_8k
2019-07-12 director, departed sec_8k
2017-06-08 Chief Commercial Officer, appointed sec_8k
2017-05-30 director, appointed sec_8k
2017-04-13 director, departed sec_8k
2017-03-30 Chief Executive Officer, appointed sec_8k
2017-03-30 director, departed sec_8k
2017-03-30 Vice Chairman, appointed sec_8k
mcp_package_hint
steadybase-$